Chronic renal graft disease;Patología crónica del injerto renal

Nefrologia

Volumn 28, Issue 4, 2008, Pages 373-380

  Vazquez Martul E ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC DISEASE; GLOMERULUS; GRAFT REJECTION; HUMAN; KIDNEY DISEASE; PATHOLOGY;

CHRONIC DISEASE; GRAFT REJECTION; HUMANS; KIDNEY DISEASES; KIDNEY GLOMERULUS;

EID: 51249094526     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (73)

1. Pontlcelli C, Villa M, Cesana B, Montagnino G, Tarantino A, Risk factors for late kidney allograft failure. Kidney Int 2002; 62(5): 1848-54.
2. Matas AJ, Humar A, Gillingham KJ y cols. Kidney Inter 2002; 62: 704-714.
3. Flechner SM, Modlin CS, Serrano DP, Goldfarb DA, Papajcik D, Mastroianni B, Goormastlc M, Novick AC, Determinants of chronic renal allograft rejection in cyclosporine-treated recipients, Transplantation 1996; 62 (9): 1235-41.
4. Kreis HA, Pontlcelli C. Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors. Transplantation 2001; 71 (11 Supl.): SS5-9.
5. Paul L. Chronic allograft nephropathy: and update. Kidney Int 1999; 56: 783-793.
6. Colvin RB. Chronic allograft nephropathy. N Engl J Med2003; 394(24): 2288-90.
7. Solez K, Colvin RB, Racusen LC, Sis B, Halloran PF, Birk PE, Campbell PM, Cascalho M, Collins AB, Demetris AJ, Drachenberg CB, Gibson IW, Grimm PC, Haas M, Lerut E, Liapis H, Mannon RB, Marcus PB, Mengel M, Mihatsch MJ, Nanklvell BJ, Nlckelelt V, Papadimltriou JC, Piatt JL, Randhawa P, Roberts I, Salinas-Madriga L, Salomon DR, Seron D, Sheaff M, Weening JJ. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy («CAN»), Am J Transplant 2007; 7 (3): 518-26.
8. Fellström B, Backman U, Larsson E, Zezina L. Immunologic and nonlmmunologic risk factors of chronic rejection, Transplantation 2001; 71: SS10-16.
9. Isoniemi H, Taskinen E, Häyry P. Histological chronic allograft damege index accurately predicts chronic renal allograft rejection. Transplantation 1994; 58: 1195-1198.
10. Furness P, Taub N, Assmann K y cols. International variation in histologic grading is large and persistent feedback does not improve reproductlbility. Am J Surg Pathol 2003; 27:805.
11. Furness PN, Phllpott CM, Chorbadjlan MT, Nicholson ML, Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication rates. Transplantation 2003; 76 (6): 969-73.
12. Furness PN. Predicting allograft survival: abundant data, but insufficient knowledge? Transplantation 2007; 83 (6): 68.
13. Nankivell BJ, Borrows RJ, Fung CL y cols, The natural history of chronic allograft nephropathy, N Eng J Med 2003; 349: 2326-33.
14. Solez K, Colvin RB, Racusen LC y cols. Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions. Am J Transplant 2008.
15. Pratschke J, Wilhelm MJ, Lusaka M y cols. Brain death and its influence on donor organ quality and outcome after transplantation, Transplantation 1999; 67: 343-348.
16. Herrero JC, Andrés A, Praga M, Morales E, Domínguez-Gil B, Carreño A, Hernández E, Morales JM. Transplant Proc 1999; 31 (6): 2281-2.
17. Terasaki PI, Gjerston DW, Cecka JM y cols, Significance of the donor age affect on Kidney transplant, Clin Transplant 1997; 11: 366.
18. Pessione F, Cohen S, Durand D, Hourmant M, Kessler M, Legendre C, Mourad G, Noel C, Peraldi MN, Pouteil-Noble C, Tuppin P, Hiesse C, Multivariate analysis of donor risk factors for graft survival in kidney transplantation, Transplantation 2003; 75 (3): 361-7.
19. Randhawa R Role of donor kidney biopsies in renal transplantation, Trasplantation 2001; 71; 1361.
20. Remuzzi G, Cravedi P, Perna A, Dimitrov BD, Turturro M, Locatelli G, Rigotti P, Baldan N, Beatini M, Valente U, Scalamogna M, Ruggenenti P. Long-term outcome of renal transplantation from older donors. N Engl J Med 2006; 354(4): 343-52.
21. Moreso F, Serón D, Gil-Vernet S y cols, Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant 1999; 14(4): 930-5.
22. Gaber LW, Moore LW, Alloway RR y cols. Glomerulosclerosis as a determinant of posttransplant function of older donor renal allografts, Transplantation 1995; 60 (4): 334-9.
23. Karpinski J, Lajole G, Cattran D y cols, Outcome of kidney transplantation from high-risk donors is determined by both structure and function. Transplantation 1999; 67 (8): 1162-7.
24. Vázquez-Martul E, Mosquera JM, Rivera CF, Hernández AA, Pertega S, Histological features with clinical impact in chronic allograft nephropathy: review of 66 cases. Transplant Proc 2004; 36 (3): 770-1.
25. Seron D, Moreso F, Protocol biopsies in renal transplantation: prognostic value of structural monitoring, Kidney Int 2001.
26. Mengel M, Gwinner W, Schwarz A, Bajeski R, Franz I, Brocker V, Becker T, Neipp M, Klempnauer J, Haller H, Kreipe H. Infiltrates in protocol biopsies from renal allografts, Am J Transplant 2007; 7 (2): 356-65.
27. Rush DN, Henry SF, Jeffery JR, Histological findings in early routine biopsies of stable renal allograft recipients, Transplantation 1994;57:208-211.
28. Nankivell BJ, Borrows RJ, Fung CL y cols. Delta análisis of postransplantation tubulolnterstitlal damage. Transplantation 2004; 78: 434-441.
29. Shishido SA, Nakai HM, Nakai H. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. JASN 2003; 14: 1046-1052.
30. Saad R, Gritsch HA, Shapiro R y cols, Clinical significance of renal allograft biopsies with «borderline changes» as defined in the Banff Schema. Transplantation 1997; 64:992-995.
31. Schweitzer EJ, Drachenberg C, Anderson L y cols. Significance of the Banff borderline biopsy, Am J Kid Dis 1996; 28: 585-588.
32. Ponticelli C, Banfi G. The case against protocol biopsies, Transplantation Proc 2002; 34: 1716-1718.
33. Morris RE. Vascular and cellular mechanisms of chronic renal allograft dysfunction, Transplantation 2001; 71 : SS 37-41.
34. Habib R, Antingnac C, Hinglais N y cols. Glomerular lesions in the transplanted kidney in children Am J Kidney Dis 1987; 3: 198-207.
35. Solez K. Internacional standardization of criteria for histologic diagnosis of chronic rejection in renal allografts. Clin Transplant 1994; 8: 345-350.
36. Mihatsch MJ, Nickeleit V, Gudat F. Morphologic criteria of chronic renal allograft rejection, Transplant Proc 1999; 31: 1295.
37. Nankivell JS, Borrows RS, Gund CL y cols. Calcineurin inhibitors nephrotoxicity: longitudinal assesment protocol histology. Transplantation 2004; 78: 557.
38. Mihatsch MJ, Kyo M, Morozuml K y cols. The side-effects of ciclosporyne A. and tacrolimus. Clin Nephrol 1998; 49: 356.
39. Takeda A, Vchlda K, Haban T y cols. Chronic cyclosporine nephropathy; long term effects of cyclosporine on renal allograft. Clin Transplant 2001; (Supl, 5): 22.
40. Falkehaln ME, Cosio FG, Sedmak DD, Progressive histologic injury in kidneys from heart and liver transplant recipients receiving cyclosporine. Transplantation 1966; 62: 364.
41. Andoh TF, Bennet WM. Chronic cyclosporine nephrotoxicity, Curr Opin Nephrol Hypertens 1998; 7:265-270.
42. Bakker RC, Koop K, Sijpkens YW. Early interstitial accumulation of collagen type I discriminates chronic rejection from chronic cyclosporine nephrotoxicity, JASN 2003; 14:2142-2149.
43. Kambham N, Nagarajan S, Shah S y cols. A novel, semiquantitative, clinically correlated calclneurin inhibitor toxicity score for renal allograft biopsies, Clin Am Soc Nephrol 2007; 2: 135-142.
44. Maryniak RK, First MR, Weis MA. Transplant glomerulopathy: evolution of morphologically distinct changes. Kidney Int 1985; 27: 799.
45. Habib R, Zurowska A, Hinglais N y cols. A specific glomerular lesion of the graft: allograft glomerulopathy, Kidney Int 1993; SS 104-111.
46. Habib R, Broyer M. Clinical significance of allograft glomerulopathy, Kidney Int 1993; 43: S95-8.
47. Gloor JM, Sethi S, Steqall MD y cols. Transplant glomerulopathy: subclinical incidence and association with alloantlbody. Am J Transplant 2007; 7: 2124-2132.
48. Andresdort MB, Assmann KJ, Koene RA y cols. Immunohistological and ultastructurral diffrerences between recurrent typel membranoproliferative glomerulonephritis and chronic transplant glomerulopthy. Am J Kidney Dis 1998; 32: 582-588.
49. Morel-Maroger L. Adult hemolytic uremic syndrome, Kidney Int 1980; 18: 125-134.
50. Vázquez Martul E, Valdês C, Alonso A y cols, Síndrome hemolítico urémlco dei adulto: características histopatológlcas, ultrastructurales y de inmunofluorescencia, Nefrologia 1984; 4: 271-280.
51. Ivanyi B. Transplant capillaropathy and transplant glomerulopathy: ultrastructural markers of chronic renal allograft rejection, Nephrol Dial Transplant 2003; 18(4): 655-60.
52. Bald S, Cosimi AB, Tolkoff-Rubin N, Colvin RB, Williams WW, Pascual M. Renal disease associated with hepatitis C infection after kidney and liver transplantation, Transplantation 2000; 70 (2): 255-61.
53. Zamurovic D, Churg J, Idiopathic and secondary mesangiocaplllary glomerulonephritis, Nephron 1984; 38 (3): 145-53.
54. Fortin MCH, Schürch W, Cardinal H, Herbert MJ. Complement factor H deficiency in acute allograft glomerulopathy and post-transplant haemolytic uremic syndrome. Am J Transpl 2003; 4: 270-273.
55. Racusen LC, Halloran PF, Solez K. Banff 2003 meeting report: new diagnostic insights and standards. Am J Transplant 2004; 4 (10): 1562-6.
56. Racusen LC, Haas M. Antibody-mediated rejection in renal allografts: lessons from pathology, Clin J Am Soc Nephrol 2006; 1 (3): 415-20.
57. Terasaki. Humoral Theory of Transplantation [Article]. American Journal of Transplantation 2003; 3 (6): 665-673.
58. De Heer E, Davldoff A, Van der Wal A y cols, Chronic renal allograft rejection in the rat, Transplantation 1994; 70: 494-502.
59. Poduval RJ, Kadambi PV, Josephson M, Cohn R y cols, Implications of immunohlstochemical detection of C4d along peritubular capillaries in late allograft rejection. Transplantation 2005; 79 (2): 228-235.
60. Sis B, Campbell PM, Mueller T, Hunter C, Cockfield SM, Cruz J, Meng C, Wishart D, Solez K, Halloran PF. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7 (7): 1743-52.
61. Regele H, Bohmig GA, Habicht A, Gollowltzer D, Schillinger M, Rockenschaub S, Watschinger B, Kerjaschki D, Exner M, Capillary deposition of complement spilt product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection, J Am Soc Nephrol 2002; 13 (9): 2371-80.
62. Monga G, Mazzucco G, Motta M y cols. Intertubular capillary changes in kidney allografts: a morphologic investigation on 61 renal specimens, Mod Pathol 1992; 5: 125-30.
63. Ivanyi B. Transplant capillaropathy and transplant glomerulopathy: ultrastructural markers of chronic renal allograft rejection, Nephrol Dial Transplant 2003; 18 (4): 655-60.
64. Alta K, Yamaguchi Y, Horita S, Ohno M, Thickening of the peritubular capillary basement membrane is a useful diagnostic marker of chronic rejection in renal allografts. Am J Transplant 2007; 7: 923-929.
65. Basile DP. Rarefaction of peritubular capillaries following ischemic acute renal failure: a potential factor predisposing to progressive nephropathy, Curr Opin Nephrol Hypertens 2004; 13(1): 1-741.
66. Sanfilippo F, Kolbeck PC, Vaugh WK, Bollinger RR. Renal allograft cell infiltrates associated with irreversible rejection. Transplantation 1985; 40: 679-684.
67. Stelzer GT, McLeish KR, Lorden RE y cols, Alterations in T lymphocyte subpoblations associated with renal allograft rejection, Transplantation 1984; 37: 261-264.
68. Kayler LK, Lakkis FG, Morgan C, Basu A y cols, Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion. Am J Transplant 2007; 7: 949- 954.
69. Charney DA, Nadasdy T, Lo AW, Racusen LC. Plasma cell-rich acute renal allograft rejection. Transplantation 1999; 68 (6): 791-7.
70. Desvaux D, Le Gouvello S, Pastural M y cols, Acute renal allograft rejections with major intertltial oedema and plasma cellrich infiltrates: hihg gamma interferron expression and poor outcome, Nephrol Dial Transplant 2004; 19: 933-939.
71. Colvin RB. Transplant Mac attack: humor the macrophages, Kidney Int 2003; 63 (5): 1953-4.
72. Magil AB. Infiltrating cell types in transplant glomerulitis: relationship to peritubular capillary C4d deposition. Am J Kidney Dis 2005; 45 (6): 1084-9.
73. Seron D, O'Valle F, Moreso F, Goma M, Hueso M, Grinyo JM, Garda del Moral R. Immunophenotype of infiltrating cells in protocol renal allograft biopsies from tacrolimus-versus cyclosporine-treated patients. Transplantation 2007; 83 (5): 649-52.